131 related articles for article (PubMed ID: 28604419)
1. Prognostic significance of cyclooxygenase 2 and phosphorylated Akt1 overexpression in primary nonmetastatic and metastatic cutaneous melanomas.
Soares CD; Borges CF; Sena-Filho M; Almeida OP; Stelini RF; Cintra ML; Graner E; Zecchin KG; Jorge J
Melanoma Res; 2017 Oct; 27(5):448-456. PubMed ID: 28604419
[TBL] [Abstract][Full Text] [Related]
2. Expression of thymidine phosphorylase and cyclooxygenase-2 in melanoma.
Minisini AM; Pascoletti G; Intersimone D; Poletto E; Driol P; Spizzo R; Scott CA; Puglisi F; Fasola G; Di Loreto C
Melanoma Res; 2013 Apr; 23(2):96-101. PubMed ID: 23411479
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of cyclooxygenase-2 (COX-2) in oral nevi and melanoma.
de Souza do Nascimento J; Carlos R; Delgado-Azañero W; Mosqueda Taylor A; de Almeida OP; Romañach MJ; de Andrade BA
J Oral Pathol Med; 2016 Jul; 45(6):440-3. PubMed ID: 26608958
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of cytoplasmic p27 expression in human melanoma.
Chen G; Cheng Y; Zhang Z; Martinka M; Li G
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2212-21. PubMed ID: 21828232
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of nuclear ING3 expression in human cutaneous melanoma.
Wang Y; Dai DL; Martinka M; Li G
Clin Cancer Res; 2007 Jul; 13(14):4111-6. PubMed ID: 17634537
[TBL] [Abstract][Full Text] [Related]
7. Association of galectin-3 expression with melanoma progression and prognosis.
Brown ER; Doig T; Anderson N; Brenn T; Doherty V; Xu Y; Bartlett JM; Smyth JF; Melton DW
Eur J Cancer; 2012 Apr; 48(6):865-74. PubMed ID: 22071132
[TBL] [Abstract][Full Text] [Related]
8. Expression of cyclo-oxygenase-2 in macrophages associated with cutaneous melanoma at different stages of progression.
Bianchini F; Massi D; Marconi C; Franchi A; Baroni G; Santucci M; Mannini A; Mugnai G; Calorini L
Prostaglandins Other Lipid Mediat; 2007 Jun; 83(4):320-8. PubMed ID: 17499752
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of activated Akt expression in melanoma: a clinicopathologic study of 292 cases.
Dai DL; Martinka M; Li G
J Clin Oncol; 2005 Mar; 23(7):1473-82. PubMed ID: 15735123
[TBL] [Abstract][Full Text] [Related]
10. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma.
Bachmann IM; Straume O; Puntervoll HE; Kalvenes MB; Akslen LA
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8606-14. PubMed ID: 16361544
[TBL] [Abstract][Full Text] [Related]
11. Expression of cyclooxygenase-2 in benign naevi and during human cutaneous melanoma progression.
Kuźbicki L; Sarnecka A; Chwirot BW
Melanoma Res; 2006 Feb; 16(1):29-36. PubMed ID: 16432453
[TBL] [Abstract][Full Text] [Related]
12. Expression of p-Akt and COX-2 in gastric adenocarcinomas and adenovirus mediated Akt1 and COX-2 ShRNA suppresses SGC-7901 gastric adenocarcinoma and U251 glioma cell growth in vitro and in vivo.
Zhang J; Zhang QY; Fu YC; Wang T; Zhang J; Xu P; Zhou X; Pu PY; Kang CS
Technol Cancer Res Treat; 2009 Dec; 8(6):467-78. PubMed ID: 19925030
[TBL] [Abstract][Full Text] [Related]
13. Bim expression is reduced in human cutaneous melanomas.
Dai DL; Wang Y; Liu M; Martinka M; Li G
J Invest Dermatol; 2008 Feb; 128(2):403-7. PubMed ID: 17637819
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral expression of cyclooxygenase-2 (COX-2) is a negative prognostic marker for patients with cutaneous melanoma.
Kuźbicki Ł; Lange D; Stanek-Widera A; Chwirot BW
Melanoma Res; 2016 Oct; 26(5):448-56. PubMed ID: 27391144
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of hyaluronan synthase 1 and 2 associates with poor prognosis in cutaneous melanoma.
Poukka M; Bykachev A; Siiskonen H; Tyynelä-Korhonen K; Auvinen P; Pasonen-Seppänen S; Sironen R
BMC Cancer; 2016 May; 16():313. PubMed ID: 27184066
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 expression is associated with infiltration of inflammatory cells in oral and skin canine melanomas.
Silveira TL; Veloso ES; Gonçalves INN; Costa RF; Rodrigues MA; Cassali GD; Del Puerto HL; Pang LY; Argyle DJ; Ferreira E
Vet Comp Oncol; 2020 Dec; 18(4):727-738. PubMed ID: 32323423
[TBL] [Abstract][Full Text] [Related]
17. Gamma-interferon-inducible lysosomal thiol reductase is upregulated in human melanoma.
Nguyen J; Bernert R; In K; Kang P; Sebastiao N; Hu C; Hastings KT
Melanoma Res; 2016 Apr; 26(2):125-37. PubMed ID: 26930048
[TBL] [Abstract][Full Text] [Related]
18. COX-1 and COX-2 expression in canine cutaneous, oral and ocular melanocytic tumours.
Pires I; Garcia A; Prada J; Queiroga FL
J Comp Pathol; 2010; 143(2-3):142-9. PubMed ID: 20207364
[TBL] [Abstract][Full Text] [Related]
19. COX-2 expression in malignant melanoma: a novel prognostic marker?
Becker MR; Siegelin MD; Rompel R; Enk AH; Gaiser T
Melanoma Res; 2009 Feb; 19(1):8-16. PubMed ID: 19430402
[TBL] [Abstract][Full Text] [Related]
20. Expression of activated Akt and PTEN in malignant melanomas: relationship with clinical outcome.
Slipicevic A; Holm R; Nguyen MT; Bøhler PJ; Davidson B; Flørenes VA
Am J Clin Pathol; 2005 Oct; 124(4):528-36. PubMed ID: 16146807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]